Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Mainz J, Narayanan S, Suthoff E, Vallier C, Bell S, MacGregor G, Herzig M, Hautamaki E, Kinnman N. 250 Patient-reported outcomes among patients (pts) with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor (IVA) compared with those homozygous for the F508del-CFTR mutation. J Cyst Fibros 2016. [DOI: 10.1016/s1569-1993(16)30489-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

For:	Mainz J, Narayanan S, Suthoff E, Vallier C, Bell S, MacGregor G, Herzig M, Hautamaki E, Kinnman N. 250 Patient-reported outcomes among patients (pts) with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor (IVA) compared with those homozygous for the F508del-CFTR mutation. J Cyst Fibros 2016. [DOI: 10.1016/s1569-1993(16)30489-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Number

Cited by Other Article(s)

Narayanan S, Mainz JG, Gala S, Tabori H, Grossoehme D. Adherence to therapies in cystic fibrosis: a targeted literature review. Expert Rev Respir Med 2017;11:129-145. [DOI: 10.1080/17476348.2017.1280399] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]